Jeffrey Cleland
Company: Ashvattha Therapeutics
Job title: Chairman, President & Chief Executive Officer
Seminars:
Optimizing Clinical Endpoints in Neuroimmunology Drug Development: Bridging the Gap from Preclinical Promise to Clinical Success 8:35 am
In the evolving field of neuroimmunology, defining and validating clinical endpoints is crucial for translating preclinical findings into successful therapies. This workshop will focus on the strategic selection and application of clinical endpoints to accurately assess efficacy and safety in neuroimmunology drug development. Participants will explore how to align endpoints with the unique challenges of…Read more
day: Pre-Conference Day AM Track A